Invention Application
- Patent Title: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
- Patent Title (中): 用于治疗癌症和免疫和自发性疾病的病毒诱导剂
-
Application No.: US13649950Application Date: 2012-10-11
-
Publication No.: US20130096121A1Publication Date: 2013-04-18
- Inventor: Le Wang , George Doherty , Xilu Wang , Zhi-Fu Tao , Milan Bruncko , Aaron R. Kunzer , Michael D. Wendt , Xiaohong Song , Robin Frey , Todd M. Hansen , Gerard M. Sullivan , Andrew Judd , Andrew Souers
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: A61K31/4725
- IPC: A61K31/4725 ; A61K31/5377 ; A61P35/02 ; C07D417/14 ; A61P35/00
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bc1-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bc1-xL protein.
Public/Granted literature
- US08940737B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Public/Granted day:2015-01-27
Information query
IPC分类:
